---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-110891"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:05:16.386395+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# TELA Bio prices $37.3M public offering of 12M shares and pre-funded warrants at $2.25/share

## Summary
- Offering consists of 12M shares at $2.25/share and 5.8M pre-funded warrants at $2.2499 each, exercisable at $0.0001.
- Net proceeds expected ~$37.3M after underwriting discounts and expenses; use for general corporate purposes including sales, marketing, R&D.
- Underwriters have a 30-day option to purchase up to an additional 2.67M shares.
- Pre-funded warrants are immediately exercisable; exercise price $0.0001; beneficial ownership cap of 9.99% or 4.99% at holder's election.

## SEC filing metadata
- accession: 0001104659-24-110891
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465924110891/0001104659-24-110891-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465924110891/tm2426723d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-110891
- JSON: https://secwatch.observer/filing/0001104659-24-110891.json
- Plain text: https://secwatch.observer/filing/0001104659-24-110891.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.